Open Access

Correction to: Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma

  • Veronika Kremer1,
  • Maarten A. Ligtenberg2,
  • Rosa Zendehdel1,
  • Christina Seitz3,
  • Annet Duivenvoorden1,
  • Erik Wennerberg4,
  • Eugenia Colón5, 6,
  • Ann-Helén Scherman-Plogell7 and
  • Andreas Lundqvist1, 8Email author
Journal for ImmunoTherapy of Cancer20175:88

https://doi.org/10.1186/s40425-017-0292-8

Received: 10 October 2017

Accepted: 10 October 2017

Published: 6 November 2017

The original article was published in Journal for ImmunoTherapy of Cancer 2017 5:73

Unfortunately, after publication of this article [1], it was noticed that the name of Maarten A. Ligtenberg was displayed incorrectly as Maarten Ligtenberg. The correct author list can be seen above and the original article has been updated to reflect this.

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Oncology-Pathology, Karolinska Institutet
(2)
Department of Molecular Oncology, The Netherlands Cancer Institute
(3)
Department of Medicine Solna, Karolinska Institutet
(4)
Department of Radiation Oncology, Weill Cornell Medicine
(5)
Department of Oncology-Pathology, Stockholm South General Hospital
(6)
Department of Woman and Child Health, Karolinska Institutet
(7)
Department of Urology, Stockholm South General Hospital
(8)
Cell Therapy Institute, Nova Southeastern University

Reference

  1. Kremer V, Ligtenberg M, Zendehdel R, Seitz C, Duivenvoorden A, Wennerberg E, Lundqvist A. Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma. Journal for Immunotherapy of Cancer. 2017;5:73. https://doi.org/10.1186/s40425-017-0275-9.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement